Longitudinal changes in neurocognitive performance related to drug use intensity in a sample of persons with and without HIV who use illicit stimulantsLongitudinal effects of cocaine and HIV on cognitive performance.

[1]  Sheri L. Towe,et al.  HIV viremia contributes to neurocognitive impairments in persons who use cocaine , 2023, Journal of NeuroVirology.

[2]  B. Brew,et al.  Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not , 2022, EClinicalMedicine.

[3]  John J. Foxe,et al.  Effects of Human Immunodeficiency Virus Infection and Former Cocaine Dependence on Neuroanatomical Measures and Neurocognitive Performance , 2022, Neuroscience.

[4]  H. Fox,et al.  An assessment of factors associated with neurocognitive decline in people living with HIV , 2021, International journal of STD & AIDS.

[5]  Sube Banerjee,et al.  Quality of life in people living with HIV-associated neurocognitive disorder: A scoping review study , 2021, PloS one.

[6]  Christopher M. Jones,et al.  Trends and correlates of cocaine use among adults in the United States, 2006-2019. , 2021, Addictive behaviors.

[7]  B. Marshall,et al.  Crack cocaine use frequency is associated with HIV disease severity independent of antiretroviral therapy exposure: a prospective cohort study , 2021, AIDS and Behavior.

[8]  B. Fischer,et al.  ‘Resurgent’, ‘twin’ or ‘silent’ epidemic? A select data overview and observations on increasing psycho-stimulant use and harms in North America , 2021, Substance Abuse Treatment, Prevention, and Policy.

[9]  A. Briasoulis,et al.  Characteristics, trends, outcomes, and costs of stimulant-related acute heart failure hospitalizations in the United States. , 2021, International journal of cardiology.

[10]  Eric C. Kutscher,et al.  Stimulant Use Disorders in the United States-Is Another Epidemic on The Horizon? , 2020, JAMA health forum.

[11]  P. Vickerman,et al.  Estimating the contribution of stimulant injection to HIV and HCV epidemics among people who inject drugs and implications for harm reduction: A modeling analysis. , 2020, Drug and alcohol dependence.

[12]  J. Berman,et al.  HIV Neuropathogenesis in the Presence of a Disrupted Dopamine System , 2020, Journal of Neuroimmune Pharmacology.

[13]  Sheri L. Towe,et al.  HIV Prevalence and Associated Risks in a Respondent-Driven Sample of Illicit Stimulant Users in a Southern United States City , 2020, AIDS and Behavior.

[14]  J. Berman,et al.  The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era , 2019, Brain Research.

[15]  L. Degenhardt,et al.  Responding to global stimulant use: challenges and opportunities , 2019, The Lancet.

[16]  D. Meyerhoff,et al.  Modeling neurocognitive and neurobiological recovery in addiction , 2019, Cognition and Addiction.

[17]  Christopher H. Johnson,et al.  Behavioral and Clinical Characteristics of Persons with Diagnosed HIV Infection—Medical Monitoring Project, United States 2016 Cycle (June 2016–May 2017) , 2019 .

[18]  J. Mahoney.  Cognitive dysfunction in individuals with cocaine use disorder: Potential moderating factors and pharmacological treatments. , 2019, Experimental and clinical psychopharmacology.

[19]  Sterling C. Johnson,et al.  Measuring longitudinal cognition: Individual tests versus composites , 2018, Alzheimer's & dementia.

[20]  J. Vera,et al.  Cognitive Impairment in people living with HIV in the ART era: A Review , 2018, British medical bulletin.

[21]  Kirsten M Frazer,et al.  The long-term effects of cocaine use on cognitive functioning: A systematic critical review , 2018, Behavioural Brain Research.

[22]  K. Brady,et al.  Association of Substance Use With Hospitalization and Virologic Suppression in a Southern Academic HIV Clinic , 2018, The American journal of the medical sciences.

[23]  I. Grant,et al.  Neuropsychological comparisons of cocaine versus methamphetamine users: A research synthesis and meta-analysis , 2018, The American journal of drug and alcohol abuse.

[24]  S. Potvin,et al.  Cognitive deficits in individuals with methamphetamine use disorder: A meta-analysis. , 2018, Addictive behaviors.

[25]  S. Shoptaw,et al.  Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection , 2018, AIDS.

[26]  J. Rehm,et al.  Health outcomes associated with crack-cocaine use: Systematic review and meta-analyses. , 2017, Drug and alcohol dependence.

[27]  A. Adimora,et al.  Cognitive trajectories over 4 years among HIV-infected women with optimal viral suppression , 2017, Neurology.

[28]  R. De La Garza,et al.  The limited impact that cocaine use patterns have on neurocognitive functioning in individuals with cocaine use disorder , 2017, Journal of psychopharmacology.

[29]  S. Martins,et al.  Patterns of drug use and HIV infection among adults in a nationally representative sample. , 2017, Addictive behaviors.

[30]  Ó. Lozano-Rojas,et al.  Impact of general cognition and executive function deficits on addiction treatment outcomes: Systematic review and discussion of neurocognitive pathways , 2016, Neuroscience & Biobehavioral Reviews.

[31]  K. Sherman,et al.  Cocaine Use and Liver Disease are Associated with All-Cause Mortality in the Miami Adult Studies in HIV (MASH) Cohort , 2016, Journal of drug abuse.

[32]  Lu Yang,et al.  Multiple Faceted Roles of Cocaine in Potentiation of HAND. , 2016, Current HIV research.

[33]  David J. Volsky,et al.  HIV-associated neurocognitive disorder — pathogenesis and prospects for treatment , 2016, Nature Reviews Neurology.

[34]  S Spudich.  Immune activation in the central nervous system throughout the course of HIV infection , 2016, Current opinion in HIV and AIDS.

[35]  M. Copenhaver,et al.  The Influence of Neurocognitive Impairment on HIV Risk Behaviors and Intervention Outcomes among High-Risk Substance Users: A Systematic Review , 2016, Front. Public Health.

[36]  J. Cadet,et al.  Neuropsychological Consequences of Chronic Drug Use: Relevance to Treatment Approaches , 2016, Front. Psychiatry.

[37]  L. Cysique,et al.  The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review , 2016, CNS Drugs.

[38]  A. Waters,et al.  Cognitive Function as a Transdiagnostic Treatment Target in Stimulant Use Disorders , 2016, Journal of dual diagnosis.

[39]  Sai V. Chitti,et al.  Interactive effects of cocaine on HIV infection: implication in HIV-associated neurocognitive disorder and neuroAIDS , 2015, Front. Microbiol..

[40]  K. Robertson,et al.  Independent effects of HIV infection and cocaine dependence on neurocognitive impairment in a community sample living in the southern United States. , 2015, Drug and alcohol dependence.

[41]  L. Norman,et al.  An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research. , 2015, Current drug abuse reviews.

[42]  S. Childers,et al.  Increased Sensitivity to Cocaine Self-Administration in HIV-1 Transgenic Rats is Associated with Changes in Striatal Dopamine Transporter Binding , 2015, Journal of Neuroimmune Pharmacology.

[43]  C. Hinkin,et al.  Interactive effects of neurocognitive impairment and substance use on antiretroviral non-adherence in HIV disease. , 2015, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[44]  Philip D. Harvey,et al.  Practice effects due to serial cognitive assessment: Implications for preclinical Alzheimer's disease randomized controlled trials , 2015, Alzheimer's & dementia.

[45]  S. Potvin,et al.  Cocaine and Cognition: A Systematic Quantitative Review , 2014, Journal of addiction medicine.

[46]  C. Kennedy,et al.  HIV-Related Neurocognitive Disorders and Drugs of Abuse: Mired in Confound, Surrounded by Risk , 2014, Current Addiction Reports.

[47]  B. Quednow,et al.  Cognitive Impairment in Cocaine Users is Drug-Induced but Partially Reversible: Evidence from a Longitudinal Study , 2014, Neuropsychopharmacology.

[48]  L. Sobell,et al.  Reliability of the Timeline Followback for cocaine, cannabis, and cigarette use. , 2014, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.

[49]  J. Ramaekers,et al.  Characterizing the cognitive effects of cocaine: A comprehensive review , 2013, Neuroscience & Biobehavioral Reviews.

[50]  B. Quednow,et al.  Cognitive dysfunctions in recreational and dependent cocaine users: role of attention-deficit hyperactivity disorder, craving and early age at onset , 2013, British Journal of Psychiatry.

[51]  T. Sterling,et al.  Active cocaine use is associated with lack of HIV-1 virologic suppression independent of nonadherence to antiretroviral therapy: Use of a rapid screening tool during routine clinic visits , 2013, AIDS care.

[52]  D. Ostrow,et al.  Cumulative exposure to stimulants and immune function outcomes among HIV-positive and HIV-negative men in the Multicenter AIDS Cohort Study , 2012, International journal of STD & AIDS.

[53]  K. Duff.  Evidence-based indicators of neuropsychological change in the individual patient: relevant concepts and methods. , 2012, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[54]  D. Tranel,et al.  Scoring Higher the Second Time Around: Meta-Analyses of Practice Effects in Neuropsychological Assessment , 2012, The Clinical neuropsychologist.

[55]  G. K. Henry,et al.  Official position of the american academy of clinical neuropsychology on serial neuropsychological assessments: the utility and challenges of repeat test administrations in clinical and forensic contexts , 2010, The Clinical neuropsychologist.

[56]  F. Altice,et al.  Neurocognitive Impairment and HIV Risk Factors: A Reciprocal Relationship , 2010, AIDS and Behavior.

[57]  Rita Z. Goldstein,et al.  The Neuropsychology of Cocaine Addiction: Recent Cocaine Use Masks Impairment , 2009, Neuropsychopharmacology.

[58]  Mardge H. Cohen,et al.  Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women , 2008, AIDS.

[59]  I. Grant,et al.  The 50 and 100-Item Short Forms of the Paced Auditory Serial Addition Task (PASAT): Demographically Corrected Norms and Comparisons with the Full PASAT in Normal and Clinical Samples , 2003, Journal of clinical and experimental neuropsychology.

[60]  R. Mattick,et al.  Choosing a cut-off on the Severity of Dependence Scale (SDS) for amphetamine users. , 1997, Addiction.

[61]  B Powis,et al.  The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. , 1995, Addiction.

[62]  A. Churchill,et al.  Measurement of the severity of amphetamine dependence. , 1993, Addiction.

[63]  D. Metzger,et al.  The Fifth Edition of the Addiction Severity Index. , 1992, Journal of substance abuse treatment.

[64]  Adam J Rubenis,et al.  Cognitive deficits in people with stimulant use disorders , 2020 .